跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Aclipak Concentrate for Solution for Infusion 6mg/ ml - HSA Drug Approval Details
Approvals
/
HSA
/
Aclipak Concentrate for Solution for Infusion 6mg/ ml
Approved
STANDARD
Aclipak Concentrate for Solution for Infusion 6mg/ ml
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
de6f67228466ef91
Company
Unknown
Type
Standard
Approval Details
Approval Id
de6f67228466ef91
Drug Name
Aclipak Concentrate for Solution for Infusion 6mg/ ml
Active Ingredients
Paclitaxel
6.00 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
de6f67228466ef91
Type
Standard
Back to HSA Approvals
